Literature DB >> 10550293

Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

S D Yan1, A Roher, A M Schmidt, D M Stern.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10550293      PMCID: PMC1866992          DOI: 10.1016/s0002-9440(10)65452-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  115 in total

Review 1.  The role of the immune system in neurodegenerative disorders.

Authors:  E G McGeer; P L McGeer
Journal:  Mov Disord       Date:  1997-11       Impact factor: 10.338

2.  Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

Authors:  K R Bales; T Verina; R C Dodel; Y Du; L Altstiel; M Bender; P Hyslop; E M Johnstone; S P Little; D J Cummins; P Piccardo; B Ghetti; S M Paul
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

3.  Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice.

Authors:  G A Carlson; D R Borchelt; A Dake; S Turner; V Danielson; J D Coffin; C Eckman; J Meiners; S P Nilsen; S G Younkin; K K Hsiao
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

4.  Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

Authors:  G M Castillo; C Ngo; J Cummings; T N Wight; A D Snow
Journal:  J Neurochem       Date:  1997-12       Impact factor: 5.372

5.  17Beta-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid beta-peptide and iron.

Authors:  J N Keller; A Germeyer; J G Begley; M P Mattson
Journal:  J Neurosci Res       Date:  1997-11-15       Impact factor: 4.164

6.  Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease.

Authors:  M Yaar; S Zhai; P F Pilch; S M Doyle; P B Eisenhauer; R E Fine; B A Gilchrest
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

Authors:  M A Pappolla; Y J Chyan; R A Omar; K Hsiao; G Perry; M A Smith; P Bozner
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

Authors:  D R Borchelt; T Ratovitski; J van Lare; M K Lee; V Gonzales; N A Jenkins; N G Copeland; D L Price; S S Sisodia
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

9.  Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red.

Authors:  D J Watson; A D Lander; D J Selkoe
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

Review 10.  M-CSF: haematopoietic growth factor or inflammatory cytokine?

Authors:  P Fixe; V Praloran
Journal:  Cytokine       Date:  1998-01       Impact factor: 3.861

View more
  4 in total

1.  Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.

Authors:  M M Sousa; S Du Yan; R Fernandes; A Guimaraes; D Stern; M J Saraiva
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 2.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.

Authors:  Lennart Mucke; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 3.  Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.

Authors:  Maria João Saraiva; Mónica Mendes Sousa; Isabel Cardoso; Rui Fernandes
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 4.  Aging is not a disease: distinguishing age-related macular degeneration from aging.

Authors:  Daniel Ardeljan; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2013-08-09       Impact factor: 21.198

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.